Chengrong Lu
- Co-authors
- Feng ZhuZigang DongAnn M. BodeFaqing TangYong‐Yeon ChoTatyana A. ZykovaWeiya MaChengshan Xu
- Topics
- Cancer-related Molecular Pathways (5 papers)MicroRNA in disease regulation (4 papers)RNA modifications and cancer (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Chengrong Lu
25 papers receiving 956 citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 629
- Oncology 202
- Cancer Research 174
- Cell Biology 103
- Epidemiology 84
Countries citing papers authored by Chengrong Lu
This map shows the geographic impact of Chengrong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengrong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengrong Lu more than expected).
Fields of papers citing papers by Chengrong Lu
This network shows the impact of papers produced by Chengrong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengrong Lu. The network helps show where Chengrong Lu may publish in the future.
Co-authorship network of co-authors of Chengrong Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Chengrong Lu. A scholar is included among the top collaborators of Chengrong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengrong Lu. Chengrong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 13 | |
| 3 | 29 | |
| 4 | 51 | |
| 5 | 11 | |
| 6 | 29 | |
| 7 | 25 | |
| 8 | 41 | |
| 9 | [Expression of NKG2D and NKG2A with their ligands MHC-I A/B and HLA-E in acute leukemia patients and its significance]. | 3 |
| 10 | 12 | |
| 11 | 54 | |
| 12 | TOPK phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells | 1 |
| 13 | 71 | |
| 14 | 301 | |
| 15 | 61 | |
| 16 | 22 | |
| 17 | 22 | |
| 18 | 27 | |
| 19 | 27 | |
| 20 | 62 |
About Chengrong Lu
Chengrong Lu is a scholar working on Cancer Research, Immunology and Biochemistry, having authored 25 papers that have together received 967 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (174 citations), Geriatrics and Gerontology (38 citations) and Molecular Biology (629 citations). Chengrong Lu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Feng Zhu, Zigang Dong, Ann M. Bode, Faqing Tang, Yong‐Yeon Cho, Tatyana A. Zykova, Weiya Ma, Chengshan Xu, Yuan Luo and Fuchu He. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.